Know the Regulatory Profile of the Company you are Investing In
RQMIS can provide an independent assessment for your potential acquisition. If you are considering making a significant investment in a start-up, acquiring assets or purchasing a medical device/biotechnology company outright an understanding of their regulatory compliance profile is critical. Although protections can be written into contracts, the amount of time and money you may have to invest in resolving disagreements can be substantial. In addition, having a better understanding of the regulatory status of the product or company you plan to purchase will assist you during the formulation of your offer.
Due diligence is not limited to regulatory compliance. Understanding the state of an ongoing clinical study will allow you to understand the status of a company's clinical validation program to appreciate the value of a medical device or biotechnology product.